Report - Brigitte Wildemann Neurologische Klinik · 2020-02-03 · Avonex®, Rebif®, Plegridy® Betaferon®, Extavia® Glatirameracetat Mayzent Copaxone®, Clift® Ocrelizumab oral Fingolimod

Please pass captcha verification before submit form